Latest filing published 17 Feb 2024 for Lincoln Pharmaceuticals Limited, €143k.
Filing timeline
BuySaleAnand Arvindbhai Patel: trading record in brief
Anand Arvindbhai Patel is a declared insider of Lincoln Pharmaceuticals Limited, with filings sourced from SEBI (PIT + SAST). The record holds 3 filings, for trades running from 15 December 2022 to 16 February 2024.
Every open-market trade on record is a purchase: 3 purchases worth €351k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings 1 purchase and no sales.
The median purchase comes to €104k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 17 February 2024 with an open-market purchase (€143k) in Lincoln Pharmaceuticals Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anand Arvindbhai Patel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ ₹641.0040.8% of flowEquity SharesSEBI:02bd575e10a0c277f448671a570daaf779ccc731Canonical exit: 16 May 2024 (T+90)
- 25,000 shares@ ₹368.0029.7% of flowEquity SharesSEBI:41d3a65e0440c3cab88e79eab74b46a55342278bCanonical exit: 16 Mar 2023 (T+90)
- 25,000 shares@ ₹365.5429.5% of flowEquity SharesSEBI:4b53454c2f8cfa3f4680db62f578d1d93e688736Canonical exit: 15 Mar 2023 (T+90)
3 of 3 declarations